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There have been significant advancements in the care of patients with a hematological 
malignancy over the past three or more decades
1
. Despite this, there still exists a significant 
mortality risk in curative treatment and many patients with a hematological malignancy will die 
from their disease
1
. A growing body of research indicates patients with a hematological 
malignancy do not receive best practice palliative and end-of-life care
2
. Shortfalls in care include 
poor referral patterns to specialist palliative care services, lack of honest discussions regarding 
death and dying, inadequate spiritual care for patients and families, patients frequently dying in 
the acute care setting and high levels of patient and family distress
2
. There have been a number 
of efforts in the United Kingdom, United States of America, Sweden, and Australia 
demonstrating palliative and hematology care can co-exist, exemplified through clinical case 
studies and innovative models of care
2
. However, deficits in the provision of palliative care for 
patients with a hematological malignancy persist as evident in the international literature
2
. 
Addressing this issue requires research exploring new aspects of a complex scenario; here we 
suggest priority areas of research. 
The Patient’s Voice 
While the experience of the bereaved caregiver and opinions of health care professionals have 
been explored
2
, to the best of our knowledge the patient’s voice is missing in the literature. 
Published case studies demonstrate successful integration of palliative care when patients are 
provided with open, honest information and treatment options
3, 4
. It is acknowledged that 
research exploring the patient’s perspective in palliative care is difficult for ethical and practical 
reasons. However, patients with a hematology malignancy are often functionally well and 
physically able to participate in research despite having advanced disease, providing the 
opportunity for valuable insights to be shared even late in their illness trajectory. Revealing the 
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patient’s voice is the next step forward in addressing the problem of inadequate palliative care 
provision for patients with a hematological malignancy. 
The Uniqueness of Hematology  
The unique nature and disease trajectory of patients with a hematological malignancy must be 
considered as these patients are much more likely to have fluctuating levels of health and to 
deteriorate rapidly to a terminal event than their solid tumor counterparts
2
. It is argued that 
current models of specialist palliative care services and end-of-life care facilities are geared 
towards patients with solid tumors who experience a slower steady decline
1,
 
5
. Treatment that is 
viewed as ‘symptom management’ by hematologists is often considered ‘active treatment’ by 
palliative care physicians and is not facilitated in palliative care units
5
. In light of these 
limitations, formal study of how well specialist palliative care services can care for patients with 
a hematological malignancy is needed. 
Contribution of cancer nurses 
In response to increasingly complex health care systems, nursing roles are expanding and 
becoming more valuable in meeting the needs of specialized patient groups
6
. Advanced practice 
nursing roles such as the role of nurse practitioner have great promise in improving holistic care 
and streamlining integration of palliative care, potentially resulting in improvements in 
symptoms, levels of emotional distress and quality of life
6
. However, much attention has focused 
on nursing competence in performing ‘medical tasks’ such as bone marrow aspirates, insertion of 
central lines and managing transfusions. The holistic model of nursing must not be undervalued 
or underutilized in advanced nursing roles. A high level of evidence supporting the effectiveness 
of these roles and models of care will be required. 
Cancer nurses can do more to improve palliative and end-of-life care provision for patients with 
a hematological malignancy. First and foremost, we need to help the patient’s voices be heard 
and understand their perspectives, perceptions and understandings. This is certainly an exciting 
time for cancer nurses, as we have significant potential to improve the complex and unmet needs 
of patients with a hematological malignancy, and help tailor palliative care to meet their specific 
needs. 
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